Steven Tropello
Founder
CoapTech
CoapTech has developed the PUMA-G System, the first FDA-cleared ultrasound-based solution for bedside gastrostomy tube placement, which enhances patient safety by visualizing tissue layers to prevent organ damage and infections. This technology significantly reduces hospital costs and lengths of stay, achieving an average savings of $26,621 per patient compared to traditional PEG procedures.
- Healthcare Technology
Updated 7 months ago
Funding
Raised to date
$24.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Traditional gastrostomy tube placement often relies on blind percutaneous endoscopic gastrostomy (PEG) procedures, which carry risks of organ damage, infection from endoscope reprocessing, and radiation exposure from fluoroscopy. Scheduling bottlenecks for operating suites can also delay patient care and increase costs.
Solution
CoapTech's PUMA-G System is an FDA-cleared, ultrasound-based solution for bedside gastrostomy tube placement. The system enables physicians and advanced practice providers to visualize tissue layers from the stomach wall to the surface, mitigating risks associated with blind sticks. By facilitating bedside procedures, the PUMA-G System reduces the need for operating suite time, leading to more efficient patient care and optimized suite productivity. The technology has been successfully implemented in various settings, including ICUs, step-down units, and long-term acute care hospitals.
Target Audience
The primary users are critical care physicians, interventional pulmonologists, general surgeons, and advanced practice providers in ICUs, step-down units, and long-term acute care hospitals.
Features
- Ultrasound visualization of tissue layers to guide gastrostomy tube placement
- Bedside procedure capability, eliminating the need for operating suite scheduling
- Reduced risk of organ damage compared to blind PEG procedures
- Minimized infection risk by avoiding endoscope reprocessing
- Elimination of radiation exposure associated with fluoroscopy